Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 090 570.6 |
96 | EP file number | EAKZ | 14 85 9634.9 |
86 | WO file number | WAKZ | PCT/US2014/064133 |
97 | EP publication number | EPN | 3065772 |
87 | WO publication number | WPN | 2015069770 |
54 | Designation/title | TI | KOMBINATIONEN AUS CHECKPOINT-INHIBITOREN UND THERAPEUTIKA ZUR BEHANDLUNG VON KREBS |
51 | IPC main class | ICM (ICMV) | A61K 39/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/39 (2006.01), A61K 39/395 (2006.01), A61K 38/20 (2006.01), C07K 16/28 (2006.01), A61N 5/10 (2006.01), A61P 35/04 (2006.01), A61P 43/00 (2006.01), A61P 35/00 (2006.01), A61P 35/02 (2006.01), A61P 37/04 (2006.01), A61K 35/15 (2025.01) |
22 | DE application date | DAT | Nov 5, 2014 |
96 | EP application date | EAT | Nov 5, 2014 |
86 | WO application date | WAT | Nov 5, 2014 |
43 | Date of first publication | OT | May 14, 2015 |
| Date of publication of grant | PET | Jul 24, 2024 |
71/73 | Applicant/owner | INH | Cognate Bioservices, Inc., Hanover, MD, US; NorthWest Biotherapeutics, Inc., Bethesda, MD, US; REVIMMUNE, INC., Hanover, MD, US; The Regents of the University of California, Oakland, CA, US |
72 | Inventor | IN | BOSCH, Marnix, Leo, Clyde Hill, WA 98004, US; GANJEI, James, Kelly, Bethesda, MD 20814, US; POWERS, Linda, F., Bethesda, MD 20814, US; LIAU, Linda, M., Los Angeles, CA 90077, US; PRINS, Robert, M., Pacific Palisades, CA 90272, US |
74 | Representative | VTR | Patentanwälte Bressel und Partner mbB, 10785 Berlin, DE |
| Address for service | | Patentanwälte Bressel und Partner mbB, 10785 Berlin, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361900309 P Nov 5, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361900355 P Nov 5, 2013
|
| Due date | FT FG | Nov 30, 2024 Annual fee for the 11th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003065772 Searchable text:
EP000003065772 Original document:
EP000003065772B1 Searchable text:
EP000003065772B1 Original document:
WO002015069770 Searchable text:
WO002015069770 |
43 | Date of first publication | EVT | May 14, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Oct 28, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | May 1, 2025 (Show all update days)(Hide all update days)- May 1, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 24.07.2024: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 24.07.2024: deleted
- Feb 6, 2025
- St.36: changed (technical change)
- Dec 19, 2024
- St.36: changed (technical change)
- Dec 10, 2024
- IPC secondary class(es): changed
- Oct 10, 2024
- Representative: new
- Address for service: changed
- Aug 8, 2024
- Procedures: Publications, DPMA mention of EP grant, 08.08.2024: new
- Jul 4, 2024; Feb 8, 2024; Sep 14, 2017
- Historical data not available for this/these date(s)
- Oct 28, 2016
- Date of the first transfer into DPMAregister
|